← Daily Brief
The Bell BriefFrom Dr. Jennifer Bell, DDS
MEDIUMClinicalTier 1

Analysis of CD4+ and CD8+ T Lymphocytes and Expression of Immune Checkpoint Proteins (PD-1 and PD-L1) in Primary and Persistent Periapical Lesions

SourceJournal of EndodonticsTier 1Peer-Reviewed Research

Originally at sciencedirect.com

Summary & scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol (Drill-Down Score) — not the original publisher.

Why it matters for dental

This study on immune-checkpoint expression in periapical lesions gives endodontists and restorative dentists early insight into why some lesions persist despite adequate root-canal treatment—potentially guiding future diagnostic or adjunctive therapies.

Key points

  • Primary vs. persistent lesion comparison shows CD4+/CD8+ ratios and PD-1/PD-L1 expression patterns that differ by lesion chronicity.
  • PD-L1 up-regulation in persistent lesions suggests an immune-evasion mechanism that may explain non-healing after conventional endodontic therapy.
  • Data come from human biopsy specimens, so findings are directly translatable to clinical decision-making for apical surgery or retreatment planning.
  • Future targeted immunotherapies (anti-PD-1/PD-L1) could emerge as adjuncts for non-responsive periapical disease.

Who should care

SpecialistAssociate

Read the original on Journal of Endodontics

Full reporting and any paywall content live on sciencedirect.com. We summarize and score; we do not republish.

Open original

Related